Geron Corporation (GERN)
NASDAQ: GERN · IEX Real-Time Price · USD
3.930
-0.020 (-0.51%)
At close: May 3, 2024, 4:00 PM
3.940
+0.010 (0.25%)
After-hours: May 3, 2024, 7:59 PM EDT
Geron Revenue
Geron had revenue of $520.00K in the twelve months ending March 31, 2024, with 5.26% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $304.00K with 1,347.62% year-over-year growth. In the year 2023, Geron had annual revenue of $237.00K, a decrease of -60.23%.
Revenue (ttm)
$520.00K
Revenue Growth
+5.26%
P/S Ratio
4,444.37
Revenue / Employee
$3,688
Employees
141
Market Cap
2.31B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 237.00K | -359.00K | -60.23% |
Dec 31, 2022 | 596.00K | -797.00K | -57.21% |
Dec 31, 2021 | 1.39M | 1.14M | 450.59% |
Dec 31, 2020 | 253.00K | -207.00K | -45.00% |
Dec 31, 2019 | 460.00K | -606.00K | -56.85% |
Dec 31, 2018 | 1.07M | 1,000.00 | 0.09% |
Dec 31, 2017 | 1.07M | -5.10M | -82.72% |
Dec 31, 2016 | 6.16M | -30.21M | -83.06% |
Dec 31, 2015 | 36.37M | 35.22M | 3,054.47% |
Dec 31, 2014 | 1.15M | -130.00K | -10.13% |
Dec 31, 2013 | 1.28M | -1.43M | -52.64% |
Dec 31, 2012 | 2.71M | 271.00K | 11.12% |
Dec 31, 2011 | 2.44M | -1.13M | -31.57% |
Dec 31, 2010 | 3.56M | 1.84M | 106.43% |
Dec 31, 2009 | 1.73M | -1.08M | -38.42% |
Dec 31, 2008 | 2.80M | -4.82M | -63.22% |
Dec 31, 2007 | 7.62M | 4.35M | 132.59% |
Dec 31, 2006 | 3.28M | -2.88M | -46.78% |
Dec 31, 2005 | 6.16M | 5.11M | 484.81% |
Dec 31, 2004 | 1.05M | -121.00K | -10.31% |
Dec 31, 2003 | 1.17M | -756.00K | -39.17% |
Dec 31, 2002 | 1.93M | -2.03M | -51.26% |
Dec 31, 2001 | 3.96M | -2.65M | -40.08% |
Dec 31, 2000 | 6.61M | 1.20M | 22.12% |
Dec 31, 1999 | 5.41M | -1.39M | -20.38% |
Dec 31, 1998 | 6.80M | -456.00K | -6.29% |
Dec 31, 1997 | 7.25M | 1.96M | 37.03% |
Dec 31, 1996 | 5.29M | -197.00K | -3.59% |
Dec 31, 1995 | 5.49M | - | - |
Dec 31, 1994 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Patterson Companies | 6.57B |
AMN Healthcare Services | 3.79B |
ICU Medical | 2.26B |
Integra LifeSciences Holdings | 1.54B |
Tandem Diabetes Care | 770.01M |
Guardant Health | 563.95M |
Inari Medical | 520.66M |
Denali Therapeutics | 330.53M |
GERN News
- 3 days ago - Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights - Business Wire
- 10 days ago - Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 17 days ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Geron to Participate at Upcoming Investor Conferences in April - Business Wire
- 6 weeks ago - Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 7 weeks ago - Can Geron Corporation maintain momentum following FDA's backing? - Invezz
- 7 weeks ago - Geron's stock soars 95% after FDA advisory panel votes in favor of blood-disorder drug - Market Watch
- 7 weeks ago - Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS - Business Wire